CAD 0.09
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 22.96 Million CAD | 48.36% |
2022 | 15.47 Million CAD | 16.52% |
2021 | 13.28 Million CAD | 6.08% |
2020 | 12.52 Million CAD | 133.61% |
2019 | 5.36 Million CAD | 1434.32% |
2018 | 349.35 Thousand CAD | -25.65% |
2017 | 469.89 Thousand CAD | 213.26% |
2016 | 150 Thousand CAD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 24.02 Million CAD | 4.63% |
2024 Q3 | 23.46 Million CAD | -0.12% |
2024 Q2 | 23.49 Million CAD | -2.22% |
2023 Q2 | 19.27 Million CAD | 17.77% |
2023 Q1 | 16.36 Million CAD | 5.73% |
2023 FY | 22.96 Million CAD | 48.36% |
2023 Q4 | 22.96 Million CAD | 9.55% |
2023 Q3 | 20.96 Million CAD | 8.77% |
2022 Q4 | 15.47 Million CAD | 10.83% |
2022 Q1 | 13.04 Million CAD | -1.79% |
2022 Q3 | 13.96 Million CAD | 0.82% |
2022 FY | 15.47 Million CAD | 16.52% |
2022 Q2 | 13.85 Million CAD | 6.18% |
2021 Q3 | 12.83 Million CAD | 4.53% |
2021 Q2 | 12.27 Million CAD | 3.0% |
2021 Q1 | 11.91 Million CAD | -4.81% |
2021 Q4 | 13.28 Million CAD | 3.52% |
2021 FY | 13.28 Million CAD | 6.08% |
2020 Q1 | 10.79 Million CAD | 101.43% |
2020 FY | 12.52 Million CAD | 133.61% |
2020 Q4 | 12.52 Million CAD | 0.77% |
2020 Q3 | 12.42 Million CAD | 20.18% |
2020 Q2 | 10.34 Million CAD | -4.23% |
2019 Q1 | 400.87 Thousand CAD | -3.89% |
2019 Q3 | 4.68 Million CAD | 25.15% |
2019 Q4 | 5.36 Million CAD | 14.41% |
2019 FY | 5.36 Million CAD | 1434.32% |
2019 Q2 | 3.74 Million CAD | 833.81% |
2018 Q4 | 417.08 Thousand CAD | -3.13% |
2018 FY | 349.35 Thousand CAD | -25.65% |
2018 Q3 | 430.56 Thousand CAD | -8.37% |
2018 Q2 | 469.89 Thousand CAD | -2.16% |
2018 Q1 | 480.26 Thousand CAD | -2.21% |
2017 Q4 | 491.12 Thousand CAD | -2.41% |
2017 Q3 | 503.26 Thousand CAD | 0.0% |
2017 FY | 469.89 Thousand CAD | 213.26% |
2016 FY | 150 Thousand CAD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 1.08 Million CAD | -2014.026% |
Decibel Cannabis Company Inc. | 142.98 Million CAD | 83.94% |
Delivra Health Brands Inc. | 10.05 Million CAD | -128.442% |
Entourage Health Corp. | 31.39 Million CAD | 26.852% |
Lifeist Wellness Inc. | 13.39 Million CAD | -71.377% |
Cannara Biotech Inc. | 141.52 Million CAD | 83.774% |
Medicure Inc. | 28.05 Million CAD | 18.162% |
PharmaCielo Ltd. | 22.28 Million CAD | -3.022% |
Rubicon Organics Inc. | 54.89 Million CAD | 58.166% |
BioSyent Inc. | 41.52 Million CAD | 44.706% |
Voyageur Pharmaceuticals Ltd. | 2.16 Million CAD | -961.304% |